Betaseron (interferon beta-1b) is a prescription drug used to treat certain types of multiple sclerosis (MS) and clinically isolated syndrome (CIS) in adults. The drug is given as an injection under ...
DUBLIN--(BUSINESS WIRE)--The "Drug Analysis: Betaseron" drug pipelines has been added to ResearchAndMarkets.com's offering. Betaseron was the first drug to reach the market that modifies the course of ...
SAN DIEGO, September 27, 2005 – Berlex, Inc., a U.S. affiliate of Schering AG Germany (FSE: SCH, NYSE: SHR) today announced updated data from the Betaseron® 16-Year Long-Term Follow-up (16-Year LTF) ...
myBETAapp This new software allows patients currently using the electronic BETACONNECT autoinjector to administer Betaseron (interferon beta-1b) to connect their autoinjector to the new myBETAapp ...
A new study of Bayer Healthcare’s blockbuster Betaseron has revealed that patients treated with the drug after their first multiple sclerosis ‘attack’ experienced a significant delay in the ...
Betaseron (interferon beta-1b) is a prescription drug used to treat clinically isolated syndrome (CIS) and certain types of multiple sclerosis (MS). This drug can interact with alcohol and other ...
San Diego, CA – Berlex announced today that Betaseron® (interferon beta 1b) remained consistently safe, effective and well tolerated over the long term, according to results of the Betaseron 16-Year ...
WAYNE, N.J., July 11 /PRNewswire/ -- Berlex, Inc. today announced the availability of Betaject(R) 3, a new autoinjection device specifically designed to work with Betaseron(R) (interferon beta-1b) as ...
How do you keep a 22-year-old injectable multiple sclerosis therapy competitive in the face of threats from high-flying oral contenders? Bayer has an idea. The company recently won FDA approval for ...
WAYNE, N.J., Jan. 8, 2011 /PRNewswire/ --- Bayer HealthCare Pharmaceuticals has become aware of a broad United States market recall of alcohol prep pads, swabs and swabsticks manufactured by the Triad ...
April 22, 2005 — The U.S. Food and Drug Administration (FDA) and Berlex, Inc., have reminded healthcare professionals via letter of the risk of hepatotoxicity associated with use of interferon beta-1b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback